Nephron Sc Inc voluntarily recalled 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bags due to potential product carryover from CGMP deviations, the FDA said on Jan. 12, 2023.
How to tell if you have it
- Brand: Nephron Sc
- Product: 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only, Nephron Pharmaceuticals Corporation
- NDC: 0487-4301-10
- UPC: 3 04874 30110 3
- Lot: 271043
- Expiration: 03/2023
- Quantity: 378 bags
The hazard
The recall addresses CGMP deviations that pose a potential for trace amounts of product carryover.
Context
GovInfoNow's records show Nephron Sc Inc has issued three other recalls since Aug. 10, 2022, including a Feb. 23, 2023 recall for Sterile Water for Injection due to potential product carryover and a Jan. 13, 2023 recall for Racepinephrine Inhaler due to short fill hazards. Other recent recalls of similar products include B. Braun Medical's Aug. 19, 2026 sodium chloride injection recall for particulate matter hazard, Fresenius Kabi's March 11, 2026 recall for lack of sterility assurance, and Baxter's Aug. 17, 2026 recall for fiberglass particulates risk.